Lupin to supply anti-TB combination to Brazil
This article was originally published in Scrip
Executive Summary
Lupin plans to supply its four-in-one combination drug for tuberculosis to Brazil, under an alliance with the country’s largest healthcare public sector undertaking, Farmanguinhos.